Clinical Trial Results:
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery: A Phase IIb, Multicentre, Randomised, Active-Controlled, Double Blind, Double Dummy, Parallel Group Study
Summary
|
|
EudraCT number |
2010-023383-40 |
Trial protocol |
BE LV HU AT BG NL PL |
Global completion date |
07 Mar 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Jun 2017
|
First version publication date |
03 Jun 2017
|
Other versions |
|
Summary report(s) |
TB-402-006 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.